Linzess (linaclotide: Was approved by fda at end of august 2012 to treat chronic idiopathic (= cause unknown) constipation & irritable bowel syndrome with constipation it's approved is for adult patients only. Increases cgmp in intestine, which stimulates secretion of chloride & bicarbonate (sodium bicarbonate) resulting in increased intestinal fluid & accelerated transit.
Answered 1/30/2013
5.3k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question